University of Minnesota Awarded $4 Million Grant to Study Brain Stimulation for Bipolar Disorder
Table of Contents
The University of Minnesota has received a $4 million grant to conduct a groundbreaking study investigating the use of personalized brain stimulation – known as Personalized and Adaptive Cortico Electrostimulation (PACE) – as a treatment for depressive symptoms in individuals with bipolar disorder. The research, beginning with enrollment in 2026, aims to not only alleviate symptoms but also to unravel the neurobiological mechanisms underlying mood swings in this complex psychiatric illness.
Understanding Bipolar Disorder and the Need for New Treatments
Bipolar disorder is a mental health condition characterized by extreme shifts in mood, energy, and activity levels. These shifts range from periods of elevated mood (mania or hypomania) to periods of depression. Current treatments, including medication and psychotherapy, are often effective but don’t work for everyone, and can have important side effects.According to the National Institute of Mental Health (NIMH),approximately 2.8% of U.S. adults experienced bipolar disorder in the past year. This highlights the urgent need for innovative and targeted therapies.
PACE: A Personalized Approach to Brain Stimulation
Personalized and Adaptive cortico Electrostimulation (PACE) offers a promising new avenue for treatment. unlike conventional brain stimulation techniques that deliver a fixed dose of stimulation, PACE dynamically adjusts the stimulation parameters based on an individual’s brain activity.This personalized approach aims to maximize therapeutic benefits while minimizing potential side effects.
“The University of Minnesota is uniquely positioned to undertake this complex and cutting-edge proposal,” said Dr. Ziad Nahas, MD, a psychiatrist with M Health Fairview. “A better understanding of what the neurobiological systems that govern bipolar disorder are and how to best modulate them will undoubtedly lead to better treatment options for a very debilitating and often deadly psychiatric illness.”
The Study’s Goals and Methodology
The University of Minnesota study will focus on identifying the specific brain circuits involved in mood regulation in bipolar disorder. By carefully monitoring brain activity during PACE treatment, researchers hope to pinpoint the optimal stimulation parameters for each individual.This will involve:
* Identifying biomarkers: Researchers will seek to identify specific brain activity patterns that predict treatment response.
* Adaptive stimulation: The PACE system will adjust stimulation intensity and frequency in real-time based on these biomarkers.
* Neurobiological investigation: The study will utilize advanced neuroimaging techniques to understand how PACE impacts brain function and connectivity.
This research is part of a larger initiative, with the third round of BD Discovery Research grants awarded to four teams nationwide, all dedicated to exploring the core mechanisms of bipolar disorder. The grants are funded by the Brain & Behaviour Research Foundation.
Looking Ahead
The findings from this study have the potential to revolutionize the treatment of bipolar disorder. By providing a more targeted and personalized approach to brain stimulation, PACE could offer significant relief to individuals struggling with this challenging condition.
For more information on studies at the Interventional Psychiatry Research Lab, contact [email protected].
Key Takeaways:
* The University of Minnesota received a $4 million grant to study brain stimulation for bipolar disorder.
* The study will utilize personalized and Adaptive Cortico Electrostimulation (PACE), a technique that adjusts stimulation based on individual brain activity.
* Researchers aim to identify the neurobiological mechanisms underlying mood swings in bipolar disorder.
* The study is expected to begin enrollment in 2026.